Pasritamig Clinical Trials (2026): 4 Studies for Metastatic Castration-resistant Prostate Neoplasms & Metastatic Hormone-sensitive Prostate Cancer

Where to Participate: All Pasritamig Trial Sites in the U.S. (109 sites across 31 states)

Every actively recruiting Pasritamigtrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Pasritamig clinical trials at a glance: phase × recruitment status

Recruiting Pasritamig clinical trials (4)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Pasritamig clinical trials by indication

Pasritamig pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Pasritamig trials (4)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Pasritamig clinical trials: frequently asked questions

How many Pasritamig clinical trials are there?

4 Pasritamig clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants.

Are Pasritamig clinical trials recruiting in 2026?

Yes — 4 Pasritamig trials are actively recruiting in 2026, with 109 U.S. sites across 31 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Pasritamig being studied for?

Pasritamig is being studied for Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. The trials are grouped by indication on this page.

What phase is Pasritamig in?

Pasritamig clinical trials span 2 Phase 3, 2 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Pasritamig clinical trials?

The lead sponsor across the most Pasritamig trials is Janssen Research & Development, LLC. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Pasritamigas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 12, 2026.